Home
Conditions
Yolk Sac Tumor

Clinical trial condition

Yolk Sac Tumor

Explore clinical trials studying Yolk Sac Tumor. Study availability and eligibility vary by location and protocol.

11 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Yolk Sac Tumor trial results

Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations: Hospital São Carlos Fortaleza, Ceará, Brazil

Hospital São Rafael Salvador, Estado de Bahia, Brazil

Hospital Santa Cruz Curitiba, Paraná, Brazil

IDOR Recife Recife, Pernambuco, Brazil

View Trial Details

Recruiting

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

NCT04715191

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +32 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

NCT07148050

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +40 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Recruiting

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

NCT06198296

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
Locations: Houston Methodist Hospital Houston, Texas, United States

View Trial Details

Recruiting

Molecular Epidemiology of Pediatric Germ Cell Tumors

NCT05564026

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Embryonal, +20 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Not Yet Recruiting

Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors

NCT07224568

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +22 more
Locations: Fred Hutch Cancer Center Seattle, Washington, United States

View Trial Details

Completed

Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children

NCT06341998

Conditions: Endodermal Sinus Tumor, Germ Cell Tumor, Mesonephroma, +4 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Completed

Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor

NCT06470464

Conditions: Disease Attributes, Endodermal Sinus Tumor, Germ Cell Tumor, +8 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Active, Not Recruiting

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

NCT02375204

Conditions: Adenocarcinoma, Carcinoma, Childhood Teratoma, +22 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Loma Linda University Medical Center Loma Linda, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View all 125 locations

View Trial Details

Active, Not Recruiting

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

NCT05103631

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
Locations: Houston Methodist Hospital Houston, Texas, United States

View Trial Details

Yolk Sac Tumor

Yolk Sac Tumor trial results

Related conditions